Jerome J. Dvonch - 02 Jan 2026 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Financial Officer
Signature
/s/ Jerome Dvonch
Issuer symbol
SNOA
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Jan 2026, 17:22:03 UTC
Previous filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DVONCH JEROME J Chief Financial Officer C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER /s/ Jerome Dvonch 02 Jan 2026 0001518735

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Restricted Stock Units Award $0 +5,000 +17% $0.000000 34,391 02 Jan 2026 Common Stock 5,000 $0.000000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2 The RSUs on the third anniversary of the grant date, or upon change of control.
F3 The RSUs were awarded and granted to Mr. Dvonch for services performed.